AGM Statement Adjusted
Tweet
Share
E-mail
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disea
- Bekaert: Update on the Share Buyback Program and the Liquidity Agreement
- IBA to coordinate LIFEDESTINY, a new European LIFE project to advance sustainable PFAS remediation
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
